CTNM
Contineum Therapeutics, Inc.Healthcare$13.44
▲ Bullish
Mkt Cap: $501.8M|Float: 25.4M|SI: 10.4%|DTC: 12.1
Data as of market close Apr 2, 2026
IV Rank
6
IV Pctl
56%
HV 20d
71.9%
52W Range
$3-$16
ATR(14)
$1.01
Exp. Move
±19.0%
P/C Ratio
0.59
Earnings
May 13
GEX Positive
DEX Long
Net Call Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
CTNM Key Options Data
- IV Rank
- 5.5%
- Total GEX
- $0.00B
- Total DEX
- $0.0M
- Max Pain
- $5.00
- Expected Move
- ±19.0%
- Put/Call OI
- 0.59
- Net Premium
- $0.0M
- Spot Price
- $13.44
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$2.55 | ±19.0% | $10.89 | $15.99 |
| 2026-06-18 | 77 | ±$5.05 | ±37.6% | $8.39 | $18.49 |
| 2026-07-17 | 106 | ±$2.50 | ±18.6% | $10.94 | $15.94 |
| 2026-08-21 | 141 | ±$3.25 | ±24.2% | $10.19 | $16.69 |
| 2026-10-16 | 197 | ±$2.75 | ±20.5% | $10.69 | $16.19 |
| 2026-12-18 | 260 | ±$4.75 | ±35.3% | $8.69 | $18.19 |
Explore CTNM options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.